American Research & Management Company Portfolio holdings
Top Buys
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$868K |
| 2 |
PVTB
PrivateBancorp Inc
PVTB
|
+$249K |
| 3 |
Glacier Bancorp
GBCI
|
+$166K |
| 4 |
Fortune Brands Innovations
FBIN
|
+$143K |
| 5 |
FISV
Fiserv Inc
FISV
|
+$139K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.27% |
| 2 | Miscellaneous | 16.86% |
| 3 | Healthcare | 15.19% |
| 4 | Consumer Staples | 12.28% |
| 5 | Financials | 9.37% |
Similar funds
American Research & Management Company's Q2 2017 Portfolio in Review
As of Q2 2017, American Research & Management Company held 363 positions worth $304M, up 8.3% from $281M the previous quarter. Its ten largest holdings account for 36% of the portfolio.
American Research & Management Company deployed $22.5M of net new capital in Q2 2017, opening 24 new positions and adding to 32 existing holdings. Its largest new stake was PrivateBancorp, Inc. Capital Trust IV Trust Preferred: 228,076 shares worth $5.7M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 27% a quarter earlier, followed by Miscellaneous and Healthcare.
On the sell side, the largest reduction was IBM, an estimated $868K trimmed.
- American Research & Management Company's largest Q2 2017 buy was PrivateBancorp, Inc. Capital Trust IV Trust Preferred: 228,076 shares worth $5.7M.
- American Research & Management Company added most to State Street SPDR ICE Preferred Securities ETF in Q2 2017, an estimated $5.38M increase.
- American Research & Management Company's biggest Q2 2017 reduction was IBM, cutting an estimated $868K.
- American Research & Management Company fully exited PrivateBancorp Inc in Q2 2017, selling an estimated $249K.
- American Research & Management Company's ten largest holdings make up 36% of its $304M portfolio in Q2 2017.
- American Research & Management Company opened 24 new positions and closed 17 in Q2 2017.
- American Research & Management Company's portfolio value rose 8.3% quarter-over-quarter to $304M.
Based on American Research & Management Company's 13F filing for Q2 2017, filed 27 Jul 2017.